People with type 2 diabetes do not make enough of the hormone glucagon-like peptide (GLP-1) receptor agonists, which are released from the intestines after eating to reduce blood glucose levels, among other things. Manmade GLP-1 medications replace this lost hormone and have amplified effects including improved glucose levels, better weight management and even decreased risk of heart attacks and stroke. This class of drugs can be an especially effective tool in managing hyperglycemia in adults with type 2 diabetes.